Novanta

NOVT

Market cap $4.07B

As the market grows increasingly top-heavy, the risks for fundamentally weaker and average-strength companies are increasing. The number of stocks losing momentum over the past year has mounted as mega-cap tech and AI-driven names rocketed higher. While there are Strong Buys to be had outside of the mega-cap tech stocks, the downside risk is mounting for the weaker ones.

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has priced its previously announced public offering of 11 million of its 6.50% tangible equity units at $50.00 per unit (equal to the stated amount per unit). The transaction is a public offering made by means of a prospectus supplement under Novanta's effective shelf registration statement. Novanta's.

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has commenced a public offering of 11 million tangible equity units, with an aggregate stated amount of $550.0 million. Each tangible equity unit will have a stated amount of $50.00 and be comprised of a prepaid stock purchase contract and a senior amortizing note due 2028, each issued by Novanta. The.

Novanta Inc. ( NOVT ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Ray Nash - Corporate Finance Leader & IR Matthijs Glastra - CEO & Chairman of the Board Robert Buckley - Chief Financial Officer Conference Call Participants Lee Jagoda - CJS Securities, Inc. Robert Mason - Robert W. Baird & Co. Incorporated, Research Division Brian Drab - William Blair & Company L.L.C.

Novanta (NOVT) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.85 per share a year ago.

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2025. Financial Highlights Three Months Ended (In millions, except per share amounts) September 26,   September 27,   2025   2024 GAAP           Revenue $ 247.8     $ 244.4   Operating Income $ 21.8     $ 32.6   Net Income $ 10.7     $ 19.2   Diluted EPS $ 0.30     $ 0.53.

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, in London. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a.

Novanta (NOVT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Pennsylvania-based Conestoga Capital Advisors reduced its Novanta stake by 168,907 shares for an estimated $20.1 million in the third quarter. The transaction represented 0.3% of Conestoga's 13F reportable AUM.

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT), a trusted technology partner to medical and advanced industrial OEMs, announced that it will host an International Organization for Standardization (ISO) working group event for humanoid robot safety standards in Barcelona, Spain, from October 27-30, 2025. This multi-year ISO initiative aims to define the safety framework guiding how humanoid robots are designed, developed, and deployed around the world. The working group will bring together.